Samsung Biologics has ranked among the top searched stocks on 6 days within the past month.


As of 9:30 AM on the 20th, Samsung Biologics is trading at 798,000 KRW, down 1.24% from the previous day. This represents a 26.67% increase compared to October 26. Samsung Biologics is known as the holding company for Samsung Group's bio business.

Over the past 5 days, individual investors have net sold 123,132 shares, while foreigners and institutions have net bought 68,691 shares and 50,328 shares, respectively.


On November 18, Samsung Biologics became a market issue with a "surge due to contract manufacturing of COVID-19 treatments."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing